Author:
Guo Hao,MacKay John Andrew
Reference36 articles.
1. Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study;Olmos;Lancet Oncol,2010
2. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity;Wilson;Lancet Oncol,2010
3. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy;Papahadjopoulos;Proc Natl Acad Sci USA,1991
4. Liposomal drug delivery systems: from concept to clinical applications;Allen;Adv Drug Deliv Rev,2013
5. Pharmacokinetics of pegylated liposomal doxorubicin;Gabizon;Clin Pharmacokinet,2003
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献